Andrew L. Pecora MD, Andrew Ip MD MS, Ching-Kun Wang MD, Stuart L. Goldberg MD, Andre H. Goy MD, Lili Brillstein, MPH, CEO, Glenn Pomerantz MD JD, Michael B. Atkins MD, and Donald M. Berwick MD
We have previously described a digital classification schema (Cota Nodal Address [CNA]) which incorporates validated prognostic elements. We propose to demonstrate that reducing variation in cancer care among similar patients might lead to decreased costs without affecting clinical benefit. Identifying variation is difficult under claims-based coding systems (i.e. ICD-10) that group cancer subtypes. We aim to use the CNA model to investigate variations in care.